SG&A Efficiency Analysis: Comparing TG Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc.

Biotech SG&A: A Decade of Strategic Spending

__timestamp	Rhythm Pharmaceuticals, Inc.	TG Therapeutics, Inc.
Wednesday, January 1, 2014	1213000	24518692
Thursday, January 1, 2015	3425000	19886580
Friday, January 1, 2016	6311000	12631689
Sunday, January 1, 2017	9518000	21977998
Monday, January 1, 2018	28080000	20759000
Tuesday, January 1, 2019	36550000	20838000
Wednesday, January 1, 2020	46125000	121812000
Friday, January 1, 2021	68486000	152137000
Saturday, January 1, 2022	92032000	83231000
Sunday, January 1, 2023	117532000	122706000

Data in motion

SG&A Efficiency: A Tale of Two Biotechs

In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of TG Therapeutics, Inc. and Rhythm Pharmaceuticals, Inc. over the past decade. From 2014 to 2023, TG Therapeutics saw a significant increase in SG&A expenses, peaking in 2021 with a 540% rise from 2014. Meanwhile, Rhythm Pharmaceuticals experienced a staggering 9,600% increase in the same period, highlighting its aggressive expansion strategy.

Key Insights

2014-2017: Both companies maintained relatively stable expenses, with TG Therapeutics consistently outspending Rhythm Pharmaceuticals.
2018-2023: A shift occurred as Rhythm Pharmaceuticals' expenses surged, surpassing TG Therapeutics by 2023.
This trend underscores the dynamic nature of biotech financial strategies, where efficient SG&A management can be a key differentiator in achieving long-term growth.

Published by

U.S. Securities and Exchange Commission

Source link

sec.gov

Date published

17 Jan 2025

Similar Statistics

AbbVie Inc. or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?

SG&A Efficiency Analysis: Comparing Pfizer Inc. and Rhythm Pharmaceuticals, Inc.

argenx SE or TG Therapeutics, Inc.: Who Manages SG&A Costs Better?

Teva Pharmaceutical Industries Limited or Rhythm Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?

Intra-Cellular Therapies, Inc. and TG Therapeutics, Inc.: SG&A Spending Patterns Compared

Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.

Cost Management Insights: SG&A Expenses for Corcept Therapeutics Incorporated and Rhythm Pharmaceuticals, Inc.

SG&A Efficiency Analysis: Comparing Rhythm Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.

Breaking Down SG&A Expenses: Rhythm Pharmaceuticals, Inc. vs MorphoSys AG

Who Optimizes SG&A Costs Better? Rhythm Pharmaceuticals, Inc. or ImmunityBio, Inc.

Selling, General, and Administrative Costs: Rhythm Pharmaceuticals, Inc. vs Dynavax Technologies Corporation

Rhythm Pharmaceuticals, Inc. and Galapagos NV: SG&A Spending Patterns Compared